Global Surface Plasmon Resonance (SPR) Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Surface Plasmon Resonance (SPR) Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Surface plasmon resonance (SPR) is the resonance oscillation of conduction electrons at the interface between negative dielectric constant materials and positive dielectric constant materials excited by incident light. Surface plasmon resonance (SPR) can detect biomolecular interactions in real time and without labels. Surface plasmon resonance (SPR) can be used in life sciences, biosensing and drug discovery.

Market Overview:

The latest research study on the global Surface Plasmon Resonance (SPR) market finds that the global Surface Plasmon Resonance (SPR) market reached a value of USD 509.64 million in 2022. It’s expected that the market will achieve USD 684.12 million by 2028, exhibiting a CAGR of 5.03% during the forecast period.

Strength

Surface plasmon resonance (SPR) can detect biomolecular interactions in real time and without labels. When polarized light strikes the conductive surface at the interface between two media, SPR occurs. This will generate an electron charge density wave called plasmon, which will reduce the intensity of reflected light at a specific angle called resonance angle in proportion to the mass on the sensor surface. Surface plasmon resonance (SPR) is mainly used in drug development, quality control and basic life science research. There is a great demand for surface plasmon resonance (SPR) in these industries, which promotes the development of SPR industry.

Weakness

Surface plasmon resonance (SPR) technology, as a general detection platform, is widely used in drug screening, scientific research and other fields, and is used for the analysis of affinity, binding specificity and concentration quantification among biomolecules. Because of the complex structure and the monopoly of core technology by some countries, the molecular interaction instrument based on this technology is expensive and difficult to popularize.

Opportunities

Surface plasmon resonance (SPR) is widely used in drug development, quality control and basic life science research. With the development of science and technology and people paying more and more attention to health, the requirements for drugs and life science products are raised, and new research and development are required, which provides opportunities for the development of SPR (Surface plasmon resonance) industry.

Threat

The technology barrier in the surface plasmon resonance (SPR) industry are relatively high, which requires certain experience for enterprises entering the industry, but the competition in the industry is also very fierce. Enterprises in some developed countries have developed science and technology, and there are many application technologies or instruments combined with Surface plasmon resonance (SPR), which occupy most markets of Surface plasmon

Region Overview:

North America had the highest growth rate of all regions.

Company Overview

The top three companies are Cytiva, Fortebio, AMETEK, Inc., with the revenue market share of 44.18%, 24.45%, 9.12% in 2019.

Cytiva is a global provider of technologies and services that can promote and accelerate the development and manufacture of therapeutic agents. Cytiva is a global leader in the field of life sciences, with more than 7,000 employees in 40 locations. Cytiva brings efficiency to research and production processes, and ensures the development and manufacture of transformed drugs. Cytiva's clients are engaged in life-saving activities from basic biological research to the development of innovative vaccines, biopharmaceuticals and new cell and gene therapies. Cytiva's job is to provide better, faster and safer tools and services, so as to improve the treatment effect of patients.

Fortebio provides solutions for biomolecule analysis, including real-time analysis of biomolecule interactions in small samples (protein quantification and characterization of interactions between proteins and biomolecules, etc.), and provides information on binding affinity, binding kinetics and concentration. Fortebio's products include instruments, software, biosensors and support services. Fortebio's customers carry out key tasks of life science research in academic, government and industrial environments, including drug research, development and manufacturing. Fortebio focuses on biomolecular interaction analysis, biosensor technology and surface chemistry, labelfree real-time analysis, protein-protein interaction, small molecule and fragment screening, antibody characterization, analysis and development, and biological process and cell line development.

Segmentation Overview:

By type, Imaging System segment accounted for the largest share of market in 2021.

Application Overview:

By application, the Drug Discovery segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Surface Plasmon Resonance (SPR) market covered in Chapter 3:

Nicoya Lifesciences Inc.
Cytiva
AMETEK, Inc.
Horiba, Ltd.
Biosensing Instrument Inc.
BiOptix Inc.
Bio-Rad Laboratories, Inc.
Kinetic Evaluation Instruments BV
Fortebio

In Chapter 4 and Chapter 14.2, on the basis of types, the Surface Plasmon Resonance (SPR) market from 2018 to 2029 is primarily split into:

Imaging System
Sensor System
Reagent

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Surface Plasmon Resonance (SPR) market from 2018 to 2029 covers:

Life Science
Biosensing
Drug Discovery
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)